Abu Dhabi’s state-backed health-care investment company, M42, has invested in the UK-based biotech startup Juvenescence, which specializes in developing drugs aimed at extending human lifespans. The investment comes at a valuation exceeding $550 million, although the exact amount invested has not been disclosed. M42 and Juvenescence will collaborate in a strategic partnership that focuses on...
